Addressing Disparities in the Quality of Breast Cancer Chemotherapy

Published in: Clinical Breast Cancer, v. 6, no. 3, Commentary, Aug. 2005, p. 267-269

Posted on on January 01, 2005

by Jennifer J. Griggs, Melony E. Sorbero

Commentary on a study in this issue that examines disparities in the quality of breast cancer adjuvant chemotherapy received by black and white women within a university setting, and found that black women are more likely than white women to have delays in administration of chemotherapy, reductions in doses, and premature discontinuation of therapy.

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.